--- title: "ChemPartner unveils updated visual identity to reflect its reputation as a trusted biopharma partner, aiming to help life science companies efficiently bring drugs to market." type: "News" locale: "en" url: "https://longbridge.com/en/news/271277483.md" description: "ChemPartner has unveiled a fresh visual identity that reflects their extensive scientific experience, flexible collaboration approach, and dedication to supporting innovative life science firms in speeding up the process of launching groundbreaking drugs. The company is based in both Shanghai and Watertown, Massachusetts. The announcement was made on January 1, 2026." datetime: "2026-01-01T14:02:38.000Z" locales: - [zh-CN](https://longbridge.com/zh-CN/news/271277483.md) - [en](https://longbridge.com/en/news/271277483.md) - [zh-HK](https://longbridge.com/zh-HK/news/271277483.md) generator: "portal-rs" --- # ChemPartner unveils updated visual identity to reflect its reputation as a trusted biopharma partner, aiming to help life science companies efficiently bring drugs to market. ChemPartner has unveiled a fresh visual identity that reflects their extensive scientific experience, flexible collaboration approach, and dedication to supporting innovative life science firms in speeding up the process of launching groundbreaking drugs. The company is based in both Shanghai and Watertown, Massachusetts. The announcement was made on January 1, 2026. ### Related Stocks - [300149.CN](https://longbridge.com/en/quote/300149.CN.md) ## Related News & Research - [Livzon Pharma buys 3.5% Xinbeijiang Pharma stake for RMB 106.7 million](https://longbridge.com/en/news/296601614.md) - [HM Exploration shares gain DTC eligibility for US trading on OTCQB](https://longbridge.com/en/news/296448374.md) - [Algorand: v5 Mainnet goes live - 22 Aug 2026](https://longbridge.com/en/news/296687546.md) - [China says US transshipment report disregards facts](https://longbridge.com/en/news/296450742.md) - [BYD debuts third-gen Tang SUV, launch set for Q4](https://longbridge.com/en/news/296577383.md) --- > **Disclaimer: This article is for reference only and does not constitute any investment advice.**